Full VWF mutation screen (Type 1 & Type 3 VWD)

Description: 
Analysis of the VWF gene by PCR amplification and sequencing of the coding region and splice junctions. Dosage analysis, via MLPA, is available as a second line test where gross deletions/ insertions are suspected.
Clinical details: 
Von Willebrand Disease is the most common hereditary bleeding disorder, typically associated with mucocutaneous bleeding (epitaxis, menorrhagia), easy bruising and bleeding post dental extraction.
Type 1 VWD is autosomal dominant, with an estimated frequency of approximately 1:100-1000. It is generally clinically & phenotypically mild, although severe Type 1 VWD is seen and there is sometimes variable penetrance within families. Mutations are heterogeneous and spread throughout the VWF gene.
Type 3 VWD is autosomal recessive and results in severe deficiency of plasma VWF. Patients suffer severe bleeding symptoms including hemarthroses, gastrointestinal bleeds and cerebral hemorrhage. Frequency is estimated at 1:500,000 to 1:2,000,000.
Reference range: 

n/a

Synonyms or keywords: 
VWF Von Willebrand disease Type 1 VWD Type 3 VWD
Units: 
n/a
Sample type and Volume required: 
1 x Edta
Call in advance: 
no
Turnaround time: 
12 weeks
Storage and transport: 
transport at ambient temperature
Contacts:
Molecular Haemostasis Laboratory at St Thomas'
020 7188 2798
Haemostasis and Thrombosis
North Wing - 4th floor
St Thomas' Hospital
Westminster Bridge Road
London SE1 7EH

Laboratory opening times
Monday - Friday 09.00 - 17.00
For clinical advice or interpretation of results, please contact the laboratory in the first instance.

Print as a PDF

Last updated: 14/03/2017